| Q1 |
1. Is the generation of spaces for discussion of the actors in the health system, including representatives of patients, health professionals, and vulnerable populations, an effective measure to prevent litigations in health? |
| Q2 |
2. Is the funding, by the State, of the creation of scientific and civilians associations to strengthen decision making in health, an effective measure to prevent litigations in health? |
| Q3 |
3. Is the creation of a public policy that clarifies explicitly the technical and administrative management of the procedures, inputs, interventions, or benefits not included in the set of benefits of the health system, an effective measure to prevent litigation in health? |
| Q4 |
4. Is the creation of a strategy that clarifies explicitly which medical inputs and procedures are excluded of the plan of attention in health, as well as the reason of exclusion, an effective measure to reduce litigations in health? |
| Q5 |
5. Are explicit strategies to protect the regulatory public institutions of health (for example, systems of incentives and sanctions) from corruption, effective measures to reduce litigation? |
| Q6 |
6. Is the institutionalization and/or strengthening of committees in the governing institution (Ministry or Secretariat of Health), which monitor and audit the activities of buying and selling of health services, as well as appropriate provision of services by health professionals, an effective measure to reduce litigations in health? |
| Q7 |
7. Is the creation of the figure and the institutionalization of the advocacy of users or patients, an effective strategy to reduce litigations in health? |
| Q8 |
8. Is the creation of spaces such as scientific advisory committees to the courts, with the purpose of supporting legal decisions with scientific evidence, an effective measure for decision-making, and also for the regulation of litigation in health? |
| Q9 |
9. Is to grant punitive power to the institutions of surveillance and control of the health system for the compliance of processes and the provision of health services an effective measure to reduce litigations in health? |
|
|
| Leadership and governance |
|
|
| Q10 |
1. Is the definition of a public policy of surveillance of litigations in health an useful strategy to regulate judicialization of health? |
| Q11 |
2. Is the creation of observatories for knowledge, monitoring, and decision making of litigation in health, integrating actors of the health, executive, and judicial sectors, an effective strategy to regulate the judicialization of health? |
| Q12 |
3. Is the training and advice by qualified personnel of the Ministry of Health to the members of courts for decision-making in relation to the right to health, an effective strategy to regulate the judicialization of health? |
| Q13 |
4. Is training and advice by qualified staff of the scientific community in health (academic staff, researchers) to the members of the courts, an effective strategy to regulate the judicialization of health? |
| Q14 |
5. Can the continuous updating of the services and/or set of features based on the needs and priorities of public health regulate litigations in health? |
| Q15 |
6. Is the establishment of priorities in health to prevent possible budgetary expenditure and, therefore, catastrophic expenditure in high cost disease an effective measure for the regulation of the judicialization of the right to health? |
| Q16 |
7. Can the implementation of institutions or agencies for evaluating health technology that have the capacity to regulate the market in health and the entry of new technologies be an effective mechanism for the regulation of judicialization of health? |
| Q17 |
8. Can the reduction of the asymmetry of information between the offer and demand of health care (access, quality, and satisfaction) be a strategy to ensure protection to the consumer and, accordingly, to regulate the judicialization of health? |
| Q18 |
9. Can the establishment of a responsible mechanism of conflict resolution in health be an effective strategy for the regulation of the judicialization of health? |
| Q19 |
10. Are to properly inform patients or family members on the right to health, the duties of the State and the system of health in relation to the guarantee of this right, strategies of empowerment for the society that will ensure equity and therefore regulate of litigations in health? |
| Q20 |
11. Is the planning and implementation of a monitoring and control system based on the guarantee of coverage of health insurers and health care providers a fair, effective, and efficient measure to reduce litigations in health? |
| Q21 |
12. Is the development of a strategic plan for the distribution and supplying of pharmacies in the nation and regional levels an effective and efficient measure to reduce litigation in health? |
|
|
| Provision of services |
|
|
| Q22 |
1. Is the explicit guarantee of financing and access to health services an action that can reduce the probability of judicialization of health? |
| Q23 |
2. Is implementing strategies of primary health care an effective and efficient mechanism to grant equity in the access and financing of health and, consequently, can it be a measure to reduce litigation in health? |
| Q24 |
3. Is the implementation of strategies to increase access to health care in rural areas (eHealth, first level health centers in rural areas or with difficult access, economic incentives for the retention of health professionals in rural areas, transportation in areas with geographic access barriers) an effective measure to regulate litigations in health? |
| Q25 |
4. Is the redistribution of financial resources for the care of vulnerable populations a measure that improves equity in health and, likewise, would reduce litigation in health? |
| Q26 |
5. Is the approval of the plan of services between different sub-sectors in segmented health systems an effective strategy to reduce inequality in access and, therefore, regulate litigations in health? |
| Q28 |
7. Is optimizing the waiting times for the provision of health services an effective measure to reduce the number of litigations in health? |
| Q29 |
8. Is the hiring of additional health personnel to optimize health care an effective measure for the reduction of litigation in health? |
| Q30 |
9. Are the mechanisms of hiring of health services by legal mechanisms effective strategies for the reduction of litigation in health? |
| Q31 |
10. Is the generation and implementation of a system of incentives for health care quality and efficiency by health professionals an effective measure to reduce litigation in health? |
| Q32 |
11. Is the establishment of inter-agency agreements for the provision of health services an effective measure to ensure the efficient access to such services and, consequently, to reduce litigation in health? |
| Q33 |
12. Is the implementation of a system of incentives to offer health services, by insurers or providers, a strategy that ensures the access to services and, therefore, guarantee the right to health effectively and efficiently? |
| Q34 |
13. Is encouraging the prescription of generic drugs an effective measure for the regulation of litigations in health? |
|
|
| Human resources |
|
|
| Q35 |
1. Is having undergraduate and graduation programs in Law Schools focused on health a good strategy to regulate litigation in health? |
| Q36 |
2. Is the timely training of health professionals and judges for decision-making in cases of judicial tutelage an effective strategy to regulate litigation in health? |
| Q37 |
3. Is the training of professionals in audit processes and health management an effective strategy to control the quality and management of health services delivery and, likewise, to prevent litigations in health? |
| Q38 |
4. Is the establishment of a certification system of professionals and of accreditation of the institutions of health for the provision of quality health services and an effective strategy to regulate litigations in health? |
| Q39 |
5. Can developing a strategic plan for the training and distribution of human resources in your country be an effective strategy to reduce and regulate litigation in health? |
|
|
| Information |
|
|
| Q40 |
1. Can the development and implementation of clinical practice guidelines or protocols be a strategy to regulate litigations in health? |
| Q41 |
2. Is the development of a national plan for the development of guides of clinical practice, protocols of management or guidelines for the provision of health services an effective strategy to regulate litigations in health? |
| Q42 |
3. Can the implementation of an information system for decision-making on access, training, and distribution of human resources in health, drug supply and acquisition of new technologies, be an effective strategy to regulate ltigations in health? |
| Q43 |
4. Is the implementation of a national system of pharmaceutical information on the access, use, quality and prices of medicines an effective strategy to regulate litigations in health? |
| Q44 |
5. Will the creation and management of an information system on the juridical processes in health allow the population to know and characterize these processes, as well as helping decision-making of the actors involved in them? |
| Q45 |
6. Is the generation of scientific evidence from research on the impact of judicialization in the management of the health system and the judicial system an effective strategy to regulate litigations in health? |
| Q46 |
7. Is the generation of scientific evidence oriented to the identification of health needs of populations an effective measure for the strategical planning of health systems and, therefore, for the regulation of litigations in health? |
|
|
| Financing |
|
|
| Q47 |
1. Is the calculation of the additional cost of the introduction of new interventions or technology in the health system an efficient and effective strategy to regulate litigations in health? |
| Q48 |
2. Can the creation of a subsystem of financing for high-cost diseases, or that may incur in budgetary or catastrophic expenditure be an effective strategy to regulate litigations in health? |
| Q49 |
3. Can the establishment of a threshold of willingness to pay for access to a new health technology be an effective and efficient strategy to regulate litigations in health? |
| Q50 |
4. Is strengthening the aid from multinational agencies for the purchase of inputs or supplies of health services an effective measure to regulate litigations in health? |
